4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-21-055685
Director sold 19,109 shares at $16.74 ($319,976)
- Director acquired 19,109 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Mitchell Stephen Ray · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-09 | Exercise or conversion : show line 1 in the form | +5,985 | $10.57 | $63,261 | 15,200 | D |
| 2021-09-09 | Exercise or conversion : show line 2 in the form | +13,124 | $12.70 | $166,675 | 28,324 | D |
| 2021-09-09 | Sale : show line 3 in the form | −19,109 | $16.74 | $319,976 | 9,215 | D |
| Open-market sales · 19,109 sh · avg $16.74 · $319,976 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-09 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −5,985 | 0 | D |
| 2021-09-09 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −13,124 | 21,876 | D |
Loading xslF345X03/doc4.xml…